{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:35:17Z","timestamp":1791974117433,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007671","name":"Fundaci\u00f3n para la Investigaci\u00f3n y la Prevenci\u00f3n del Sida en Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.medcli.2020.01.036","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T17:35:58Z","timestamp":1590600958000},"page":"441-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efectividad y seguridad de inhibidores de integrasa en la gestante con infecci\u00f3n VIH en la Cohorte de embarazadas de la Comunidad de Madrid"],"prefix":"10.1016","volume":"155","author":[{"given":"Marta","family":"Ill\u00e1n Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mazariegos Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Prieto Tato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luisa","family":"Navarro G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy","family":"Mu\u00f1oz G\u00e1lligo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Tom\u00e1s","family":"Ramos Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2020.01.036_bib0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/15284336.2018.1459343","article-title":"Raltegravir versus lopinavir\/ritonavir for treatment of HIV-infected latepresenting pregnant women","volume":"19","author":"Brites","year":"2018","journal-title":"HIV Clin Trials."},{"key":"10.1016\/j.medcli.2020.01.036_bib0060","doi-asserted-by":"crossref","first-page":"385.e1-7","DOI":"10.1016\/j.ajog.2015.12.052","article-title":"Integrase inhibitors in late pregnancy and rapid HIV viral load reduction","volume":"214","author":"Rahangdale","year":"2016","journal-title":"Am J Obstet Gynecol."},{"key":"10.1016\/j.medcli.2020.01.036_bib0065","unstructured":"Grupo de expertos de la Secretar\u00eda del Plan Nacional sobre el SIDA (SPNS), Grupo de Estudio de SIDA (GeSIDA)\/Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia (SEGO) y Sociedad Espa\u00f1ola de Infectolog\u00eda Pedi\u00e1trica (SEIP). Documento de consenso para el seguimiento de la infecci\u00f3n por el VIH en relaci\u00f3n con la reproducci\u00f3n, embarazo, parto y profilaxis de la transmisi\u00f3n vertical del ni\u00f1o expuesto [acceso Ene 2018]. Disponible en: http:\/\/gesidaseimc.org\/wpContent\/uploads\/2018\/01\/gesida_borrador_9_ene_GUIA_PRACTICA_PA RA_EL_SEGUIMIENTO_DE_LA_INFECCION_POR_VIH_EN_LA_REPR ODUCCION.pdf"},{"key":"10.1016\/j.medcli.2020.01.036_bib0070","unstructured":"Gilleece Y, Tariq S, Bamford A, Bhagani S, Byrne L, Clarke E, et al. British HIV Association Guidelines for the management of HIV infection in pregnant women 2018 [acceso Dic 2018]. Disponible en: http:\/\/www.bhiva.org\/file\/WrhwAPoKvRmeV\/BHIVA-Pregnancyguidelinesconsultation-draft-final.pdf"},{"key":"10.1016\/j.medcli.2020.01.036_bib0075","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.4081\/idr.2017.7017","article-title":"Antiretroviral therapy containing raltegravir to prevent mother-to-child transmission of HIV in infected pregnant women","volume":"9","author":"Cecchini","year":"2017","journal-title":"Infec Dis Rep."},{"key":"10.1016\/j.medcli.2020.01.036_bib0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1056\/NEJMc1807653","article-title":"Neural-tube defects with dolutegravir treatment from the time of conception","volume":"379","author":"Zash","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2020.01.036_bib0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1157\/13090377","article-title":"Caracter\u00edsticas maternas en una cohorte de gestantes con infecci\u00f3n por el VIH-1","volume":"127","author":"Sol\u00eds","year":"2006","journal-title":"Med Clin."},{"key":"10.1016\/j.medcli.2020.01.036_bib0090","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/INF.0b013e31826fe968","article-title":"Low rates of mother to child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007","volume":"31","author":"Prieto","year":"2012","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.medcli.2020.01.036_bib0095","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1016\/S2214-109X(18)30218-3","article-title":"Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: An observational study","volume":"6","author":"Zash","year":"2018","journal-title":"Lancet Glob Health."},{"key":"10.1016\/j.medcli.2020.01.036_bib0100","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1186\/s12879-014-0700-3","article-title":"Birth defects in a cohort of infants born to HIV-infected women in Spain, 20002009","volume":"14","author":"Prieto","year":"2014","journal-title":"BMC Infect Dis."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320302074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320302074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:51:23Z","timestamp":1758419483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775320302074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0025775320302074"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2020.01.036","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efectividad y seguridad de inhibidores de integrasa en la gestante con infecci\u00f3n VIH en la Cohorte de embarazadas de la Comunidad de Madrid","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2020.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}